ロード中...
Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma
Efavirenz is an anti-viral agent of non-nucleoside reverse transcriptase inhibitor category used as a part of highly active retroviral therapy for the treatment of infections of human immune deficiency virus type-1. A simple, sensitive and rapid reversed—phase high performance liquid chromatographic...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5432066/ https://ncbi.nlm.nih.gov/pubmed/28505168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0174777 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|